share_log

CVS Health | 10-K: Annual report

西维斯健康 | 10-K:年度报表

SEC announcement ·  02/07 06:55
Moomoo AI 已提取核心信息
CVS Health Corporation (CVS Health) reported a robust financial performance for the year ended December 31, 2023. Total revenues increased by 10.9% to $357.776 billion, driven by growth across all segments. Operating income surged by 72.8% to $13.743 billion, primarily due to the absence of opioid litigation charges recorded in the previous year. Net income attributable to CVS Health saw a significant rise of 93.6% to $8.344 billion. The company's Health Care Benefits segment reported a 16.3% increase in premiums, contributing to a 15.6% rise in total revenues for the segment. The Health Services segment's total revenues grew by 10.2%, with product revenues up 8.1%. The Pharmacy & Consumer Wellness segment saw a 7.5% increase in total revenues, with pharmacy same store sales climbing by 13.6%. CVS Health completed the acquisitions of Signify...Show More
CVS Health Corporation (CVS Health) reported a robust financial performance for the year ended December 31, 2023. Total revenues increased by 10.9% to $357.776 billion, driven by growth across all segments. Operating income surged by 72.8% to $13.743 billion, primarily due to the absence of opioid litigation charges recorded in the previous year. Net income attributable to CVS Health saw a significant rise of 93.6% to $8.344 billion. The company's Health Care Benefits segment reported a 16.3% increase in premiums, contributing to a 15.6% rise in total revenues for the segment. The Health Services segment's total revenues grew by 10.2%, with product revenues up 8.1%. The Pharmacy & Consumer Wellness segment saw a 7.5% increase in total revenues, with pharmacy same store sales climbing by 13.6%. CVS Health completed the acquisitions of Signify Health and Oak Street Health, enhancing its care delivery capabilities. The company also realigned its segments, forming a new Health Services segment and a new Pharmacy & Consumer Wellness segment. Looking ahead, CVS Health plans to focus on growth in its new Cordavis, Oak Street Health, and Signify Health businesses, while navigating competitive pressures and regulatory changes. The company expects to continue sharing a larger portion of rebates with clients and faces increasing competitive pressures in the retail pharmacy industry.
CVS Health Corporation(CVS Health)报告称,截至2023年12月31日的年度财务表现强劲。受所有细分市场增长的推动,总收入增长了10.9%,达到3577.76亿美元。营业收入激增了72.8%,达到137.43亿美元,这主要是由于去年没有记录在案的阿片类药物诉讼费用。归属于CVS Health的净收入大幅增长了93.6%,达到83.44亿美元。该公司的医疗保健福利板块报告保费增长了16.3%,使该细分市场的总收入增长了15.6%。健康服务板块的总收入增长了10.2%,产品收入增长了8.1%。药房和消费者健康板块的总收入增长了7.5%,药房同店销售额增长了13.6%...展开全部
CVS Health Corporation(CVS Health)报告称,截至2023年12月31日的年度财务表现强劲。受所有细分市场增长的推动,总收入增长了10.9%,达到3577.76亿美元。营业收入激增了72.8%,达到137.43亿美元,这主要是由于去年没有记录在案的阿片类药物诉讼费用。归属于CVS Health的净收入大幅增长了93.6%,达到83.44亿美元。该公司的医疗保健福利板块报告保费增长了16.3%,使该细分市场的总收入增长了15.6%。健康服务板块的总收入增长了10.2%,产品收入增长了8.1%。药房和消费者健康板块的总收入增长了7.5%,药房同店销售额增长了13.6%。CVS Health完成了对Signify Health和Oak Street Health的收购,增强了其医疗服务能力。该公司还调整了其细分市场,成立了新的健康服务板块和新的药房和消费者健康板块。展望未来,CVS Health计划专注于其新的Cordavis、Oak Street Health和Signify Health业务的增长,同时应对竞争压力和监管变化。该公司预计将继续与客户分享更大比例的折扣,零售药房行业面临越来越大的竞争压力。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息